Insights - Page 50 of 107 - LucidQuest Ventures

Neuroscience Today — October 29, 2025

October 29, 2025novartis,Duchenne Muscular Dystrophy,BioPharma and Tech News,epilepsy,AI drug discovery,Neuroscience News,Zenas BioPharma,Limb-Girdle Muscular Dystrophy,Relapsing multiple sclerosis,RNA-targeting therapeuticsAntibody–oligonucleotide conjugates,BridgeBio

Get up to speed with this week’s neuroscience news, featuring clinical…

by LucidQuest

Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD

October 29, 2025Respiratory,clinical trials,market access,Regulatory,COPD,biopharma,Lucid Diligence Brief,payer access,diligence,RNAioligonucleotides

Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD Professional…

by Timos Papagatsias

Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC

October 28, 2025Oncology,clinical trials,Regulatory,prostate cancer,biopharma,Lucid Diligence Brief,payer access,diligence,antibody-drug conjugates,B7-H3market landscape

Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC Professional…

by Timos Papagatsias

Endocrinology Today — October 28, 2025

October 28, 2025sanofi,BioPharma and Tech News,obesity,thyroid cancer,osteoporosis,type 2 diabetes,Oral Semaglutide,Endocrinology News,Bone healthCardiovascular risk reduction,Entera Bio

Endocrinology news this week covers major developments, updates, launches and…

by LucidQuest

Obesity Today — October 28, 2025

October 28, 2025wegovy,BioPharma and Tech News,obesity,GLP-1,Novo Nordisk,mazdutide,Hengrui Pharma,type 2 diabetes,Obesity News,GLP-1/GIPHRS9531,TERN-601

Catch the latest obesity news, featuring industry updates, clinical progress,…

by LucidQuest

Lucid Diligence Brief: Guardant Health and Zephyr AI partnership

October 28, 2025real world data,clinical trials,Regulatory,AI in healthcare,precision oncology,biopharma,Lucid Diligence Brief,payer access,diligence,biomarker discovery,liquid biopsy,companion diagnosticsSaMD

Lucid Diligence Brief: Guardant Health and Zephyr AI partnership Professional…

by Timos Papagatsias

Obesity Video Recap — October 28, 2025

October 28, 2025BioPharma and Tech News,obesityGLP-1,Eli Lilly,mazdutide,Hengrui Pharma,type 2 diabetes,ASC30,Orforglipron,Innovent Biologics,Obesity News,GLP-1/GIP

Join us for this biweekly roundup of obesity news, where we summarize important…

by LucidQuest

Hematology Today — October 27, 2025

October 27, 2025gsk,Multiple Myeloma,BioPharma and Tech News,Blenrep,CLL,Revuforj,NPM1-mutated AML,Bexobrutideg,HDP-101Hematology News,concizumab

This week in hematology: the latest clinical updates, industry progress, and…

by LucidQuest

Oncology Video Recap — October 27, 2025

October 27, 2025merck,novartis,immunotherapy,breast cancer,BioPharma and Tech News,Ovarian Cancer,Targeted Therapy,bladder cancer,Keytruda,Oncology NewsRectal cancer,Ribociclib

In this biweekly edition, we cover the most significant developments shaping…

by LucidQuest

Oncology Today — October 27, 2025

October 27, 2025merck,pfizer,breast cancer,BioPharma and Tech News,Glioblastoma,bladder cancer,Small Cell Lung Cancer,Oncology News,Non-small cell lung cancer,safusidenibIDH1-mutant glioma,nasopharyngeal carcinoma

This week’s oncology update spotlights key developments, clinical updates, and…

by LucidQuest

AI in Healthcare and Digital Health Today—October 27, 2025

October 27, 2025BioPharma and Tech News,rheumatoid arthritisOpenAI,AI in Healthcare and Digital Health,finalspark,oscar health,sk biopharmaceuticals,alpha-thalassemia,chronic obstructive pulmonary disease,strabismus

This weekly roundup of AI in healthcare spans tools, care, and oversight,…

by Timos Papagatsias

Lucid Diligence Brief: Novartis to acquire Avidity Biosciences

October 27, 2025clinical trials,Regulatory,DMD,biopharma,RNA therapeutics,Lucid Diligence Brief,payer access,diligence,M&A,neuromuscular disease,DM1FSHD

Lucid Diligence Brief: Novartis to acquire Avidity Biosciences Professional…

by Timos Papagatsias

Minimize Uncertainty – Make Informed Decisions – Succeed